Cary Street Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$972K Buy
39,500
+75
+0.2% +$1.73K 0.02% 500
2026
Q1
$943K Buy
39,425
+965
+3% +$23.6K 0.02% 451
2025
Q4
$870K Hold
38,460
0.02% 468
2025
Q3
$775K Sell
38,460
-7,300
-16% -$122K 0.02% 482
2025
Q2
$653K Buy
45,760
+525
+1% +$6.14K 0.02% 497
2025
Q1
$475K Buy
+45,235
New +$512K 0.02% 547

Other funds holding ELAN

Cary Street Partners's ELAN Position: Q2 2026 in Review

Cary Street Partners increased its Elanco Animal Health (ELAN) stake by 0.19% in Q2 2026, buying an estimated $1.73K and bringing the position to 39,500 shares worth $972K. The position accounts for 0.02% of the portfolio, ranked #500.

Cary Street Partners first reported a position in ELAN in Q1 2025 and has held it in 6 quarters since. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Cary Street Partners held 39,500 shares of Elanco Animal Health worth $972K as of Q2 2026.
  • Cary Street Partners bought 75 Elanco Animal Health shares in Q2 2026, an estimated $1.73K.
  • Elanco Animal Health made up 0.02% of Cary Street Partners's portfolio in Q2 2026, its #500 holding.
  • Cary Street Partners first reported a position in Elanco Animal Health in Q1 2025 and has held it in 6 quarters since.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.